2ϩ signals that occur in smooth muscle cells, but modulation of these signals by glutamate is poorly understood. Here, using high-speed confocal imaging, we measured the Ca 2ϩ signals that occur in arteriole smooth muscle cells of newborn piglet tangential brain slices, studied signal regulation by glutamate, and investigated the physiological function of heme oxygenase (HO) and carbon monoxide (CO) in these responses. Glutamate elevated Ca 2ϩ spark frequency by ϳ188% and reduced global intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) to ϳ76% of control but did not alter Ca 2ϩ wave frequency in brain arteriole smooth muscle cells. Isolation of cerebral arterioles from brain slices abolished glutamate-induced Ca 2ϩ signal modulation. In slices treated with L-2-␣-aminoadipic acid, a glial toxin, glutamate did not alter Ca 2ϩ sparks or global [Ca 2ϩ ]i but did activate Ca 2ϩ waves. This shift in Ca 2ϩ signal modulation by glutamate did not occur in slices treated with D-2-␣-aminoadipic acid, an inactive isomer of L-2-␣-aminoadipic acid. In the presence of chromium mesoporphyrin, a HO blocker, glutamate inhibited Ca 2ϩ sparks and Ca 2ϩ waves and did not alter global [Ca 2ϩ ]i. In isolated arterioles, CORM-3 [tricarbonylchloro(glycinato)ruthenium(II)], a CO donor, activated Ca 2ϩ sparks and reduced global [Ca 2ϩ ]i. These effects were blocked by 1H-(1,2,4)-oxadiazolo-(4,3-a)-quinoxalin-1-one, a soluble guanylyl cyclase inhibitor. Collectively, these data indicate that glutamate can modulate Ca 2ϩ sparks, Ca 2ϩ waves, and global [Ca 2ϩ ]i in arteriole smooth muscle cells via mechanisms that require astrocytes and HO. These data also indicate that soluble guanylyl cyclase is involved in CO activation of Ca 2ϩ sparks in arteriole smooth muscle cells. calcium spark; calcium wave; global calcium REGIONAL NEURONAL ACTIVITY modulates local brain blood flow through a response termed functional hyperemia (12, 16) . Such local blood flow regulation functions to match O 2 and nutrient demands to cellular requirements by altering the contractility of vascular smooth muscle cells (SMCs) within the arteries and arterioles that supply the vicinity of the active neurons. In the brain, vascular SMCs can receive regulatory input from multiple cell types, including the endothelium, neurons, astrocytes, and pericytes (16) . Each of these cell types can modulate vascular SMC contractility, thereby contributing to functional hyperemia.
Glutamate is the principal excitatory cerebral neurotransmitter. One important physiological function of glutamate is to dilate cerebral arterioles to match blood flow to neural activity. Astrocytes are one candidate cell type for the mediation of the glutamate-induced neurovascular coupling to elicit vasodilation (13, 24, 32, 39, 40) . Parenchymal arterioles are surrounded by astrocytic endfeet, and pial arterioles lay on the glia limitans and are covered with astrocyte processes and endfeet (13, 24, 27, 42 (2, 7, 8, 43) . Astrocyte-derived vasoactive mediators that have been described to elicit this response include epoxyeicosatrienoic acids (3, 30) , K ϩ (8, 36), ATP (34) , and heme oxygenase (HO)-2-derived carbon monoxide (CO) (29) .
CO appears to be a major astrocyte-derived cerebral vasodilator, particularly in newborns (27, 29) . Exogenous CO applied to SMCs or HO-derived CO generated within SMCs elevates Ca 2ϩ spark frequency and increases the Ca 2ϩ sensitivity of SMC large-conductance Ca 2ϩ -activated K ϩ (K Ca ) channels (18, 19, 41) . These changes elevate transient K Ca current frequency and enhance K Ca channel coupling to localized intracellular Ca 2ϩ transients termed Ca 2ϩ sparks, which elevates transient K Ca current amplitude. The resulting increase in K Ca current causes membrane hyperpolarization, leading to a reduction in voltage-dependent Ca 2ϩ channel activity, and vasodilation (9, 18, 29 
METHODS
Tissue preparation. The animal procedures used were approved by the Animal Care and Use Committee of the University of Tennessee. Newborn pigs (1-3 days old, 1-2.5 kg) were anesthetized with ketamine hydrochloride (33 mg/kg im) and acepromazine (3.3 mg/kg im). The brain was removed and placed in M199 with 10 mM HEPES and 10 mM glucose at 4°C (pH 7.37). Tangential slices (ϳ200 m thick) were cut from the cerebral cortical surface and maintained in M199. Where required, cerebral arteries (50 -200 m in diameter) were manually harvested, cleaned, and maintained in ice-cold (4°C) physiological saline solution (PSS) containing (in mM) 112 NaCl, 4.8 KCl, 26 NaHCO 3, 1.8 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, and 10 glucose and gassed with 74% N2-21% O2-5% CO2 (pH 7.4). To selectively injure astrocytes in brain slices, slices were treated with L-2-␣-aminoadipic acid (L-AAA; 2 mM, 2 h). Control slices were incubated with D-2-␣-aminoadipic acid (D-AAA), an inactive isomer.
Confocal Ca 2ϩ imaging. Brain slices and isolated arterioles were incubated in HEPES-buffered PSS containing fluo-4-AM (10 M) for 25 min at room temperature followed by a 30-min wash. Brain slices were transferred to a recording chamber with constant perfusion (3-5 ml/min) of PSS containing U-46619 (10 nM), a thromboxane A2 receptor agonist, at 35°C to promote arterial tone. Isolated arterioles were imaged in an extracellular bath solution of the following composition (in mM): 110 NaCl, 30 KCl, 10 HEPES, 2 CaCl2, 1 MgCl2, and 10 glucose (pH 7.4 with NaOH). This methodology has been previously performed to depolarize arteries to approximately Ϫ40 mV, a membrane potential similar to that of cerebral arteries pressurized to 60 mmHg (5, 18, 20, 22, 23) . SMCs within the wall of in situ and isolated arterioles were imaged using a Noran Oz laser scanning confocal microscope (Noran Instruments, Middleton, WI) and a ϫ60 water-immersion objective (numerical aperture ϭ 1.2) attached to a Nikon TE300 microscope. Cells were illuminated with a kryptonargon laser at 488 nm, and emitted light Ͼ500 nm was collected. Planar images (56.3 ϫ 52.8 m) were recorded every 16.7 ms, i.e., 60 images/s. Laser intensity was kept low to prevent cell damage during arteriole SMC Ca 2ϩ imaging. Individual arteriole SMCs were identified based on their perpendicular orientation to the arteriole wall. At least two different representative areas of each arteriole were scanned for at least 10 s under each condition to determine spark and wave frequency and global [Ca 2ϩ ]i. The same arteriole area was scanned only once to avoid any laser-induced changes in Ca 2ϩ signaling. Imaging was performed at least 15 min (unless otherwise stated) after exposure to drugs so that measurements reflect the steady-state responses of SMCs. Control data and the effects of drugs were measured using the same arteriole segment (i.e., paired experiments). Therefore, each n value refers to data obtained from a single brain slice. Ca 2ϩ sparks, waves, and global [Ca 2ϩ ]i were analyzed in SMCs using custom analysis software written by Drs. M. T. Nelson and A. D. Bonev (University of Vermont) using IDL 5.2 (Research Systems, Boulder, CO). Automated and manual detection of Ca 2ϩ sparks were performed by dividing an area of 1.54 m (7 pixels) ϫ 1.54 m (7 pixels) (i.e., 2.37 m 2 ) in each image (F) by a baseline (F0) that was determined by averaging 10 images without Ca 2ϩ spark activity. A Ca 2ϩ spark was defined as a localized increase in F/F0 that was Ͼ1.2 (5). Ca 2ϩ waves were defined as a F/F0 elevation Ͼ1.2 that propagated for at least 10 m. Global Ca 2ϩ fluorescence was calculated from the same images used for Ca 2ϩ spark analysis and was the mean arteriole pixel value of 600 different images acquired over 10 s. To calculate global Ca 2ϩ changes, the mean global pixel value in glutamate was divided by the corresponding control value.
Statistical analysis. Values are expressed as means Ϯ SE. Statistical significance was calculated using one-way ANOVA followed by Student-Newman-Keuls test for multiple comparisons and Student's t-test for comparing paired and unpaired data. P Ͻ 0.05 was considered significant.
RESULTS

Glutamate modulates local and global Ca
2ϩ signals in arteriole SMCs of brain slices. Localized Ca 2ϩ sparks and propagating Ca 2ϩ waves occurred in SMCs of newborn pig brain slice arterioles (Fig. 1, A-C (Fig. 3, A-C signal modulation in arteriole SMCs, slices were exposed to L-AAA, a selective astrocyte toxin, or D-AAA, an inactive isomer, for 2 h before being imaged. This treatment protocol produces histological evidence of injury to the superficial glia limitans and loss of astrocyte-dependent cerebrovascular responses without altering responses in general (27, 29, 42) . L-AAA prevented both glutamate-induced Ca 2ϩ spark activation and the reduction in global [Ca 2ϩ ] i (Fig. 4, A and C) . In contrast, in L-AAA-treated slices, glutamate increased Ca 2ϩ wave frequency by ϳ129% (Fig. 4B) . In D-AAA-treated slices, glutamate activated Ca 2ϩ sparks, did not alter Ca 2ϩ wave frequency, and reduced global [Ca 2ϩ ] i , similarly to in control slices (Figs. 2, A-C, and 4, A-C ] i to ϳ83% of control (Fig. 6) (7, 8) . Rather, global intracellular Ca 2ϩ oscillations were reported in neonatal (postnatal days 1-7) and juvenile (Ͼ20 days old) rat parenchymal arterioles and adult mouse arterioles in cortical brain slices (7, 8 cerebral arteriole preparations studied; 2) conditions (e.g., U-46619 concentration: 100 -150 nM in Refs. 7 and 8 vs. 10 nM in the present study); 3) PO 2 , which modifies astrocytemediated responses to glutamate (Ref. 11; solutions in the present study were gassed with 21% O 2 vs. 95% in Refs. 7 and 8); 4) animal species (rat and mouse vs. piglet in the present study); and 5) imaging system temporal and spatial resolution, which can limit the ability to observe rapid and localized Ca 2ϩ signals, such as Ca 2ϩ sparks. Given the small number of studies that measured local and global Ca 2ϩ signals in SMCs of brain slice arterioles, future investigations will be required to better understand these different observations. Global brain intracellular glutamate concentrations are ϳ1 mM, and extracellular concentrations are within the range of 1-10 M (6, 31). Pathological conditions, including hypoxia and brain injury, can elevate brain glutamate concentrations 50-fold (6) . Under the conditions used here, glutamate concentrations that reach cells within brain slices are likely to be far lower than those applied. Furthermore, local glutamate concentrations within the vicinity of cells nearby those that release glutamate are likely to be higher than global estimates. Therefore, we studied Ca 2ϩ signal regulation by 30 M glutamate, which is likely to produce a local physiological glutamate concentration within the slice. Glutamate elevated Ca 2ϩ spark frequency and reduced global [Ca 2ϩ ] i in arteriole SMCs in brain slices. These data are consistent with glutamate acting as a vasodilator (27, 29 (21) . These data suggest that glutamate-induced vasodilation in newborn cerebral arterioles occurs due to K Ca channel activation and the subsequent decrease in global [Ca 2ϩ ] i , as recently proposed (29) . In contrast, glutamate did not alter Ca 2ϩ wave frequency. In SMCs, Ca 2ϩ waves can occur due to the activation of sarcoplasmic reticulum membrane RyR channels and/or inositol (1,4,5)-trisphosphate-gated Ca 2ϩ release channels (14, 20) . The physiological function of intracellular Ca 2ϩ waves in SMCs is unclear, but these signals have been proposed to either contribute to contraction or to have no effect on contractility (14, 15, 38) . Glutamate did not alter intracellular Ca 2ϩ signals in SMCs of isolated cerebral arterioles, indicating that an extravascular cell type(s) was the glutamate receptor and signal mediator to SMCs. U-46619 was applied to slices, whereas isolated arterioles were studied in a solution containing 30 mM K ϩ . Each of these stimuli causes SMC depolarization and arterial constriction. U-46619 has been used as a vasoconstrictor in studies using brain slices, and 30 mM K ϩ has been used in many studies to depolarize arterial SMCs to a voltage (Ϫ40 mV) similar to that in arteries at physiological pressure (5, 7, 8, 11, 18, 20, 22, 23) . U-46619 likely activates thromboxane receptors on multiple cell types within the slice, including on SMCs. U-46619 was not used in isolated arterioles because vasoconstrictors block Ca 2ϩ sparks, activate Ca 2ϩ waves, and elevate global [Ca 2ϩ ] i , which is a different Ca 2ϩ signaling phenotype than that observed in SMCs within brain slices exposed to U-46619 (20) . Therefore, we used U-46619 to depolarize brain slice arterioles and 30 mM K ϩ to depolarize isolated arterioles. These protocols allow a comparison of these new data with those in previous studies. We anticipate that depolarization with U-46619 or 30 mM K ϩ is unlikely to alter responses to glutamate.
To investigate a role for astrocytes, we used L-AAA, a glial cell-specific toxin that at the concentration and time period of exposure used, kills astrocytes, disrupts cortical glia limitans, and blocks arteriole dilation to glutamate but not to sodium nitroprusside (a nitric oxide donor), isoproterenol (a ␤-adrenergic receptor agonist), or CO (27, 29) . L-AAA also strongly inhibits cerebrovascular dilation to glutamate in newborn cortical slices and in vivo (27, 29 35). Since cerebral arterioles receive input from both neurons and astrocytes (4, 16, 37) , another explanation for these data is that in the absence of functional astrocytes, glutamate activates arteriole SMC Ca 2ϩ waves through a neuron-dependent mechanism. This conclusion is consistent with our finding that glutamate did not activate Ca 2ϩ waves in SMCs of isolated arterioles where astrocytes are absent. These data also indicate that, in the intact brain, glutamate typically reduces Ca 2ϩ wave frequency through effects on astrocytes, which is also consistent with this excitatory neurotransmitter acting as a vasodilator. Conceivably, in glutamate, functional astrocytes may inhibit Ca 2ϩ waves and another brain cell type may activate Ca 2ϩ waves, leading to no net change in Ca 2ϩ wave frequency, as observed. Although not the focus of this study, this hypothesis deserves future attention. When the control data in Fig. 4 , A and B, were compared, there was a small difference in absolute mean Ca 2ϩ spark and wave frequency between D-AAA and L-AAA, but this was not statistically significant. In support of a lack of effect, D-AAA (control: 53 Ϯ 2 m, 5 h; and D-AAA, 52 Ϯ 3 m, n ϭ 9, P Ͼ 0.05) and L-AAA did not alter pial arteriole diameters in anesthetized piglets (27) . In summary, findings indicate that astrocyte-dependent and -independent pathways fine tune glutamate modulation of different local and global Ca 2ϩ signals in arteriole SMCs. We have previously shown that in newborn pigs, glutamateinduced cerebral arteriole dilation requires astrocyte-derived HO-2-generated CO (29) . CO causes vasodilation by enhancing the apparent Ca 2ϩ sensitivity of SMC K Ca channels, leading to enhanced coupling to Ca 2ϩ sparks (18, 19, 41) . Consistent with these observations, astrocyte-derived CO and exogenous CO cause vasodilation that is inhibited by K Ca channel blockers (28, 29 (25) . CrMP was chosen to complement previous work, which used this blocker to study cerebral arteriole diameter regulation by HO-2. We also demonstrated that exogenous CO activates Ca 2ϩ sparks in SMCs of isolated arterioles. Thus, data suggest that astrocyte-derived CO activates Ca 2ϩ sparks in arteriole SMCs. In response to an elevation in astrocyte-derived CO, the Ca 2ϩ spark frequency elevation and increased Ca 2ϩ spark to K Ca channel coupling would combine to significantly elevate SMC K Ca current.
ODQ, a highly selective, membrane-permeant sGC inhibitor, was used to inhibit sGC. We (25) have previously shown that ODQ blocks vasodilation to sodium nitroprusside in anesthetized piglets and that this effect can be reversed with 8-bromo-cGMP. ODQ elevated Ca 2ϩ wave frequency but did not change Ca 2ϩ sparks in SMCs. These data suggest that a sGC activator, perhaps basal nitric oxide from endothelial cells, may suppress Ca 2ϩ waves without altering Ca 2ϩ sparks. Data also indicate that CO activation of Ca 2ϩ sparks requires sGC. In contrast to the requirement of sGC for CO activation of Ca 2ϩ sparks, CO directly activates K Ca channels (19) . Our data provide one explanation to an important question regarding the necessity of sGC for CO-induced vasodilation and the "permissive-enabling" function of the cGMP/PKG pathway. Although sGC inhibition does not prevent CO-induced K Ca channel activation in SMCs, sGC inhibition blocks CO-induced vasodilation (19, 25, 41) . However, clamping cGMP constant returns the dilation to CO (25) . Our data indicate that for CO to cause vasodilation, it must both activate K Ca channels directly and stimulate Ca 2ϩ sparks through sGC. COinduced K Ca channel activation alone in the absence of the Ca 2ϩ spark frequency elevation appears to be insufficient to significantly alter membrane potential and reduce voltagedependent Ca 2ϩ channel activity. Similarly, K Ca channel inhibition blocks CO-induced vasodilation (18) . Thus, CO-induced 
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